Addex Therapeutics (ADXN) Revenue (2012 - 2026)
Addex Therapeutics (ADXN) revenue from Sep 30, 2012 to Mar 31, 2026. The TTM Addex Therapeutics (ADXN) revenue is $113K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Addex Therapeutics (ADXN) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -41.18% |
| 3 Years TTM | -60.13% |
| 5 Years TTM | -50.69% |
| 10 Years TTM | -18.69% |
| All Time TTM | -19.33% |
Annual Revenue change of Addex Therapeutics (ADXN)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | -100.00% |
| 2025 | $38K | -91.41% |
| 2024 | $441K | -76.96% |
| 2023 | $1.91M | +24.60% |
| 2022 | $1.54M | -52.01% |
| 2021 | $3.20M | -21.53% |
| 2020 | $4.08M | +42.95% |
| 2019 | $2.85M | -53.51% |
| 2018 | $6.14M | +1096.51% |
| 2017 | $513K | +2510.71% |
| 2016 | $20K | -50.80% |
| 2015 | $40K | -55.89% |
| 2014 | $91K | -10.17% |
| 2013 | $101K | -23.14% |
| 2012 | $131K | -95.63% |
| 2011 | $3M | +41.58% |
| 2010 | $2.12M | N/A |
Comparison Addex Therapeutics (ADXN) five years revenue CAGR with competitors
Addex Therapeutics (ADXN) five years revenue CAGR is -51.13%.